These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7194409)

  • 21. Chronic treatment with haloperidol or fluphenazine decanoate: regional effects on dopamine and serotonin metabolism in primate brain.
    Bacopoulos NG; Bustos G; Redmond DE; Roth RH
    J Pharmacol Exp Ther; 1982 Apr; 221(1):22-8. PubMed ID: 6174729
    [No Abstract]   [Full Text] [Related]  

  • 22. [Problem of neuronal reception and the dopamine hypothesis of schizophrenia].
    Lideman RR; Zlobina GP; Mukhin AG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):762-9. PubMed ID: 6106337
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacological profiles of three new, potent and selective dopamine receptor agonists: N-0434, N-0437 and N-0734.
    Van der Weide J; De Vries JB; Tepper PG; Horn AS
    Eur J Pharmacol; 1986 Jun; 125(2):273-82. PubMed ID: 3743637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of antidepressant drugs on dopamine uptake and metabolism.
    Waldmeier PC
    J Pharm Pharmacol; 1982 Jun; 34(6):391-4. PubMed ID: 6124625
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of calcium antagonists nifedipine and flunarizine on phencyclidine-induced changes in the regional dopaminergic metabolism of the rat brain.
    Etou K; Kuroki T; Tatebayashi Y; Tashiro N; Hirano M
    Biochem Pharmacol; 1996 Jan; 51(1):83-6. PubMed ID: 8534272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol.
    Asper H; Baggiolini M; Burki HR; Lauener H; Ruch W; Stille G
    Eur J Pharmacol; 1973 Jun; 22(3):287-94. PubMed ID: 4738903
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term changes in the sensitivity of pre-and postsynaptic dopamine receptors in mouse striatum evidenced by behavioural and biochemical studies.
    Martres MP; Costentin J; Baudry M; Marcais H; Protais P; Schwartz JC
    Brain Res; 1977 Nov; 136(2):319-37. PubMed ID: 922486
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of striatal dopaminergic receptors in amphetamine-induced behavioral facilitation.
    Conway PG; Uretsky NJ
    J Pharmacol Exp Ther; 1982 Jun; 221(3):650-5. PubMed ID: 7201019
    [No Abstract]   [Full Text] [Related]  

  • 29. Atropine manipulation of elevated cerebral dopamine turnover caused by haloperidol or substituted benzamide drugs.
    Elliott PN; Jenner P; Marsden CD
    J Pharm Pharmacol; 1978 Dec; 30(12):788-91. PubMed ID: 32246
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of nucleus accumbens dopamine in the neurochemical and behavioral effects of phencyclidine: a microdialysis and behavioral study.
    Steinpreis RE; Salamone JD
    Brain Res; 1993 May; 612(1-2):263-70. PubMed ID: 8330204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the relevance of preferential increases of mesolimbic versus striatal dopamine turnover for the prediction of antipsychotic activity of psychotropic drugs.
    Waldmeier PC; Maître L
    J Neurochem; 1976 Aug; 27(2):589-97. PubMed ID: 989496
    [No Abstract]   [Full Text] [Related]  

  • 32. Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferation.
    Carvey PM; Hitri A; Goetz CG; Tanner CM; Klawans HL
    Life Sci; 1988; 42(22):2207-15. PubMed ID: 3374255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of cholecystokinin octapeptide on striatal dopamine metabolism and on apomorphine-induced stereotyped cage-climbing in mice.
    Kovács GL; Szabó G; Penke B; Telegdy G
    Eur J Pharmacol; 1981 Jan; 69(3):313-9. PubMed ID: 6260512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of diazepam on regional brain homovanillic acid following phencyclidine or delta 9-tetrahydrocannabinol.
    Bowers MB; Hoffman FJ
    Biochem Pharmacol; 1989 Jul; 38(14):2385-7. PubMed ID: 2546566
    [No Abstract]   [Full Text] [Related]  

  • 35. Phencyclidine-induced stereotyped behavior and serotonergic syndrome in rat.
    Martin JR; Berman MH; Krewsun I; Small SF
    Life Sci; 1979 Apr; 24(18):1699-703. PubMed ID: 573357
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of subchronic haloperidol and sulpiride on regional brain dopamine metabolism in the rat.
    Lindefors N; Sharp T; Ungerstedt U
    Eur J Pharmacol; 1986 Oct; 129(3):401-4. PubMed ID: 3780852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug actions on dopamine turnover in the median eminence.
    Moore KE; Gudelsky GA
    Adv Biochem Psychopharmacol; 1977; 16():227-35. PubMed ID: 883543
    [No Abstract]   [Full Text] [Related]  

  • 38. On the significance of endogenous 3-methoxytyramine for the effects of centrally acting drugs on dopamine release in the rat brain.
    Westerink BH; Spaan SJ
    J Neurochem; 1982 Mar; 38(3):680-6. PubMed ID: 7057187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of mecamylamine on the fate of dopamine in striatal and mesolimbic areas of rat brain; interaction with morphine and haloperidol.
    Ahtee L; Kaakkola S
    Br J Pharmacol; 1978 Feb; 62(2):213-8. PubMed ID: 564219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restoration of locomotor activity in mice by low L-DOPA doses after suppression by alpha-methyltyrosine but not by reserpine.
    Ahlenius S; Andén NE; Engel J
    Brain Res; 1973 Nov; 62(1):189-99. PubMed ID: 4358099
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.